Browse
S-Space
College of Medicine/School of Medicine (의과대학/대학원)
Pathology (병리학전공)
Journal Papers (저널논문_병리학전공)
Bile acid-mediated induction of cyclooxygenase-2 and Mcl-1 in hepatic stellate cells
- Authors
- Kim, Kang Mo; Yoon, Jung-Hwan; Gwak, Geum-Youn; Kim, Won; Lee, Sung Hee; Jang, Ja June; Lee, Hyo-Suk
- Issue Date
- 2006-02-21
- Publisher
- Academic Press
- Citation
- Biochem. Biophys. Res. Commun. 342 (2006) 1108-1113.
- Keywords
- Animals; Apoptosis/drug effects/*physiology; Cell Line; Cell Survival/drug effects; Chenodeoxycholic Acid/administration & dosage/*metabolism; Cyclooxygenase 2/*metabolism; Dose-Response Relationship, Drug; Hepatocytes/drug effects/*metabolism; Humans; Neoplasm Proteins/*metabolism; Proto-Oncogene Proteins c-bcl-2/*metabolism; Rats; Signal Transduction/drug effects/physiology
- Abstract
- In cholestatic liver diseases, bile acids induce hepatocyte apoptosis and thus cause liver injury, but hepatic stellate cells (HSCs) survive in the presence of bile acids. We attempted to analyze anti-apoptotic signaling pathways in HSCs against bile acid-induced apoptosis. In immortalized human HSCs and primarily cultured rat HSCs, bile acid treatment increased the expression levels of cyclooxygenase-2 (COX-2) and Mcl-1. COX-2 induction was found to be due to transcriptional enhancement dependent on p42/44, p38 MAPK, and JNK activation, whereas Mcl-1 induction resulted from bile acid-mediated protein stabilization in a Raf-1-dependent manner. Moreover, the inhibitions of either COX-2 activity by celecoxib or Mcl-1 induction by siRNA transfection rendered HSCs susceptible to bile acid-induced apoptosis. These results imply that the bile acid-mediated inductions of COX-2 and Mcl-1 may lead to HSC survival in cholestatic liver diseases.
- ISSN
- 0006-291X
- Language
- English
- Files in This Item: There are no files associated with this item.
- Appears in Collections:
- College of Medicine/School of Medicine (의과대학/대학원)Pathology (병리학전공)Journal Papers (저널논문_병리학전공)
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.